JBIOVSLABT• 6 Months (Normalized)
JBIO vs LABT (Jade Biosciences Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Mar, 21 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
JBIO Performance $17.14
+23.4%
Jade Biosciences Inc.
Normalized Baseline0.00%
LABT Performance $1.86
-97.85%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin JBIO LEADS
+121.25%
JBIO outperforming by 121.25%
JBIOLABT
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
JBIO LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | JBIO Price | JBIO Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $17.14 | +23.40% | $1.86 | -97.85% | +121.25% |
| Sep 16, 2026 | $16.65 | +19.87% | $2.09 | -97.58% | +117.45% |
| Sep 15, 2026 | $17.38 | +25.13% | $2.17 | -97.49% | +122.62% |
| Sep 14, 2026 | $18.18 | +30.89% | $2.12 | -97.55% | +128.44% |
| Sep 11, 2026 | $17.89 | +28.80% | $2.22 | -97.43% | +126.23% |
| Sep 10, 2026 | $19.14 | +37.80% | $2.05 | -97.63% | +135.43% |
| Sep 09, 2026 | $19.06 | +37.22% | $2.32 | -97.32% | +134.54% |
| Sep 08, 2026 | $19.45 | +40.03% | $2.18 | -97.48% | +137.51% |
| Sep 04, 2026 | $19.90 | +43.27% | $1.88 | -97.83% | +141.10% |
| Sep 03, 2026 | $19.85 | +42.91% | $1.90 | -97.80% | +140.71% |
| Sep 02, 2026 | $21.40 | +54.07% | $2.07 | -97.61% | +151.68% |
| Sep 01, 2026 | $21.02 | +51.33% | $2.76 | -96.81% | +148.14% |
| Aug 31, 2026 | $21.36 | +53.78% | $2.50 | -97.11% | +150.89% |
| Aug 28, 2026 | $20.84 | +50.04% | $2.30 | -97.34% | +147.38% |
| Aug 27, 2026 | $21.29 | +53.28% | $2.49 | -97.12% | +150.40% |
Page 1 of 9